| Developers: | Egnite |
| Date of the premiere of the system: | March 2021 g |
| Branches: | Pharmaceuticals, medicine, healthcare |
2021: Start of sales CardioCare - programs for detecting heart disease
In early March 2021, the California company egnite introduced CardioCare software based on artificial intelligence, which can detect structural heart diseases according to an echocardiogram. CardioCare is already in use in more than 50 US hospitals.
Structural heart diseases include valve and heart wall abnormalities that develop due to aging, injuries, or infections. Structural changes can lead to serious problems, including stroke, heart failure, or sudden cardiac arrest. Experts note that effective treatment of structural heart diseases begins with proper diagnosis and comprehensive observation.
Typically, patients with similar problems treat symptoms such as chest pain, irregular heartbeat, shortness of breath, dizziness, fatigue, swelling of the abdomen, ankles, or feet. The software CardioCare allows to increase detection of structural lesions when using standard examination, echocardiography.
CardioCare software is a certified cloud solution that uses an intuitive AI-based software platform. CardioCare connects to hospital data to collect and process information about cardiac patients. By analyzing various trends, the software identifies patients with the highest probability of structural heart lesions, thereby reducing the variability of diagnosis, which can delay the provision of care.
The platform also offers clients to use the services of clinical consultants who provide ongoing support to hospitals. These consultants help the hospital integrate software into clinical practice, offer advanced management techniques, and help physicians interpret software data.[1]
Notes
| The site content is translated by machine translation software powered by PROMT. The machine-translated articles are not always perfect and may contain errors in vocabulary, syntax or grammar. Read original article If you find inaccuracies or errors in the results of machine translation, please write to editor@tadviser.ru. We will make every effort to correct them as soon as possible. |